[Intrathecal opioid medication for perioperative analgesia in severely handicapped children undergoing spinal operations]. / Intrathekale Opioidmedikation zur perioperativen Analgesie bei schwer behinderten Kindern mit Wirbelsäulenoperationen.

PURPOSE OF THE STUDY: Intrathecal opioids have been shown to be safe and effective for postoperative analgesia in healthy children for spinal surgery. The aim of this study was to evaluate the applicability of intrathecal opioids in severely handicapped children scheduled for spinal surgery. METHODS: With hospital ethical committee approval, patients with physical states III and IV of the ASA classification requiring spinal surgery were retrospectively studied. In addition to inhalational anesthesia with sevoflurane or intravenous anesthesia using propofol, morphine 20 microg/kgBW and sufentanil 1.5 microg/kgBW were administered intrathecally before surgery. After surgery an infusion of nalbuphine was started. Need for additional intraoperative and postoperative analgesics, time of extubation, postoperative pain scores and p(a)CO2 values as well as adverse effects were recorded. RESULTS: A total of 28 patients aged from 2.8 to 18.5 years (median 11.6 years) were studied. Immediate tracheal extubation in the operating room was possible in 17 patients and for 11 patients delayed extubation was elected. All patients were extubated within 24 h except for 1 patient who received massive postoperative transfusions. In 26 out of 28 patients (93%) the combination of intrathecal opioids with postoperative nalbuphine provided adequate analgesia. Observed side effects were post-operative nausea and vomiting (PONV), pruritus and moderate hypoventilation. In two patients a change to intravenous morphine therapy was necessary. CONCLUSION: The use of intrathecal opioids for perioperative pain control from spinal fusion in severely handicapped children is feasible. Intrathecal opioids provide adequate postoperative analgesia and allow early extubation without persisting relevant respiratory compromise in most of these patients.

Cuffed endotracheal tubes in children reduce sevoflurane and medical gas consumption and related costs.

BACKGROUND: This study aims to evaluate sevoflurane and anaesthetic gas consumption using uncuffed vs. cuffed endotracheal tubes (ETT) in paediatric surgical patients. METHODS: Uncuffed or cuffed ETT were used in paediatric patients (newborn to 5 years) undergoing elective surgery in a randomized order. Duration of assessment, lowest possible fresh gas flow (minimal allowed FGF: 0.5 l/min) and sevoflurane concentrations used were recorded. Consumption and costs for sevoflurane and medical gases were calculated. RESULTS: Seventy children (35 uncuffed ETT/35 cuffed ETT), aged 1.73 (0.01-4.80) years, were enrolled. No significant differences in patient characteristics, study period and sevoflurane concentrations used were found between the two groups. Lowest possible FGF was significantly lower in the cuffed ETT group [1.0 (0.5-1.0) l/min] than in the uncuffed ETT group [2.0 (0.5-4.3) l/min], P<0.001. Sevoflurane consumption per patient was 16.1 (6.4-82.8) ml in the uncuffed ETT group and 6.2 (1.1-14.9) ml in the cuffed ETT group, P=0.003. Medical gas consumption was 129 (53-552) l in the uncuffed ETT group vs. 46 (9-149) l in the cuffed ETT group, P<0.001. The total costs for sevoflurane and medical gases were 13.4 (6.0-67.3)euro/patient in the uncuffed ETT group and 5.2 (1.0-12.5)euro/patient in the cuffed ETT group, P<0.001. CONCLUSIONS: The use of cuffed ETT in children significantly reduced the costs of sevoflurane and medical gas consumption during anaesthesia. Increased costs for cuffed compared with uncuffed ETT were completely compensated by a reduction in sevoflurane and medical gas consumption.

Evaluation of a new recommendation for improved cuffed tracheal tube size selection in infants and small children.

BACKGROUND: The purpose of this study was to evaluate a new recommendation for tracheal tube size selection using second-generation Microcuff paediatric endotracheal tubes (PETs) with optimized outer diameter (OD) of the distal tube. METHODS: With Ethics Committee approval, patients aged from birth to 5 years, requiring general anaesthesia with orotracheal intubation, were included. Tracheal tube sizes were selected as follows: internal diameter (ID) 3.0 mm, birth (if > or =3 kg) to <6 months; ID 3.5 mm, 6 to <18 months; ID 4.0 mm, 18 months to <3 years; ID 4.5 mm, 3 to <5 years. Tracheal tubes with the cuff not inflated were classified as too large if no air leak was obtained at an airway pressure of < or =20 cmH2O. Post-intubation stridor requiring therapy was noted. RESULTS: Three hundred and fifty children were studied. Nine tracheal tubes (2.6%) were too large and had to be exchanged: in patients requiring tracheal tubes of ID 3.0 mm and 3.5 mm, three and four tracheal tubes, respectively, and, in patients requiring tracheal tubes of ID 4.0 mm and 4.5 mm, one tracheal tube in each group. In three patients (0.9%), post-intubation stridor occurred which required therapy. CONCLUSION: The new recommendation presented for the use of second-generation Microcuff PETs with improved OD to ID ratio allows the selection of cuffed tracheal tubes with larger IDs than previously recommended for small children without increased need for tracheal tube exchange or increased incidence of post-intubation stridor in these age groups.

Non-invasive monitoring of haemoglobin concentration in paediatric surgical patients using near-infrared spectroscopy.

We evaluated the near-infrared spectroscopy based tissue haemoglobin index for continuous non-invasive monitoring of haemoglobin concentration during paediatric surgery. Blood samples from 40 children (from birth to 16 years old) were analysed oximetrically. From the first blood sample the tissue haemoglobin index/haemoglobin concentration coefficient was calculated for further tissue haemoglobin index-derived haemoglobin concentrations in each patient. Comparison of corresponding values revealed a bias and precision of -0.02 and 5.41 g.l(-1), respectively. Sensitivity and specificity of tissue haemoglobin index were 73.1% and 70.0%, respectively, for predicting falling haemoglobin concentration values. Currently, the tissue haemoglobin index is not suitable for monitoring haemoglobin concentration in children undergoing surgery.